Get the Stockscreener App
7.00
0.43%
0.03
Passage Bio Inc stock is traded at $7.00, with a volume of 66,858.
It is up +0.43% in the last 24 hours and up +24.78% over the past month.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
See More
Previous Close:
$6.97
Open:
$7.03
24h Volume:
66,858
Relative Volume:
0.35
Market Cap:
$22.25M
Revenue:
-
Net Income/Loss:
$-68.80M
P/E Ratio:
-5.9829
EPS:
-1.17
Net Cash Flow:
$-59.06M
1W Performance:
-2.51%
1M Performance:
+24.78%
6M Performance:
+1,650%
1Y Performance:
+838.21%
1-Day Range:
$6.87
$7.235
1-Week Range:
$6.83
$7.50
52-Week Range:
$0.257
$7.75
Passage Bio Inc Stock (PASG) Company Profile
Name
Passage Bio Inc
Sector
Industry
Phone
(267) 866-0312
Address
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Compare PASG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
7.00 | 22.44M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-24 | Resumed | Wedbush | Outperform |
| Sep-03-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-08-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-19-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-01-21 | Initiated | Raymond James | Outperform |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| Mar-04-21 | Upgrade | Goldman | Neutral → Buy |
| Feb-04-21 | Initiated | Guggenheim | Buy |
| Jan-25-21 | Initiated | Wedbush | Outperform |
| Jan-04-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-11-20 | Initiated | Citigroup | Neutral |
| Aug-14-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-25-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-25-20 | Initiated | Chardan Capital Markets | Buy |
| Mar-24-20 | Initiated | Cowen | Outperform |
| Mar-24-20 | Initiated | Goldman | Buy |
| Mar-24-20 | Initiated | JP Morgan | Overweight |
View All
Passage Bio Inc Stock (PASG) Latest News
Using data models to predict Passage Bio Inc. stock movement2025 Trade Ideas & Safe Entry Momentum Stock Tips - Newser
How to integrate Passage Bio Inc. into portfolio analysis toolsLong Setup & Low Risk High Win Rate Picks - Newser
Visual trend scoring systems applied to Passage Bio Inc.Short Setup & Low Drawdown Momentum Ideas - Newser
How moving averages guide Passage Bio Inc. trading2025 Market WrapUp & Safe Capital Growth Tips - Newser
Short interest data insights for Passage Bio Inc.Market Movers & Advanced Swing Trade Entry Plans - Newser
Will Passage Bio Inc. stock recover after recent drop2025 Market Outlook & AI Forecasted Entry/Exit Points - Newser
Risk adjusted return profile for Passage Bio Inc. analyzed2025 Valuation Update & Real-Time Stock Movement Alerts - Newser
How high can Passage Bio Inc. stock go2025 Bull vs Bear & Weekly Breakout Watchlists - Newser
Long term hold vs stop loss in Passage Bio Inc.July 2025 WrapUp & Community Trade Idea Sharing Platform - Newser
Has Passage Bio Inc. found a price floor2025 Biggest Moves & Low Risk High Win Rate Picks - Newser
Using R and stats models for Passage Bio Inc. forecastingRate Cut & Weekly Chart Analysis and Trade Guides - Newser
Advanced analytics toolkit walkthrough for Passage Bio Inc.July 2025 Movers & Precise Swing Trade Entry Alerts - Newser
Visual analytics tools that track Passage Bio Inc. performance2025 Market Trends & Expert Curated Trade Ideas - Newser
Passage Bio Inc. stock outlook for YEAR2025 Volatility Report & Weekly Consistent Profit Watchlists - Newser
Combining price and volume data for Passage Bio Inc.Weekly Market Outlook & Accurate Intraday Trade Tips - Newser
How hedge fund analytics apply to Passage Bio Inc. stock2025 Market Outlook & Low Risk Profit Maximizing Plans - Newser
Will Passage Bio Inc. Benefit From Sector TailwindsJuly 2025 Gainers & Real-Time Stock Entry Alerts - beatles.ru
Can Passage Bio Inc. recover in the next quarterJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - Newser
Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet - MSN
Analyzing Passage Bio Inc. with risk reward ratio chartsJuly 2025 Update & Breakout Confirmation Trade Signals - Newser
When is the best time to exit Passage Bio Inc.Portfolio Gains Summary & Daily Price Action Insights - Newser
Published on: 2025-09-08 21:23:23 - Newser
Backtesting results for Passage Bio Inc. trading strategiesWeekly Trend Recap & Daily Oversold Bounce Ideas - Newser
Chart based exit strategy for Passage Bio Inc.Treasury Yields & Real-Time Volume Triggers - Newser
Strategies to average down on Passage Bio Inc.2025 Earnings Impact & Reliable Breakout Stock Forecasts - Newser
Passage Bio Inc Stock (PASG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):